Bulk order orladeyo
Ended Awarded Last action
- Contract number
- 36C26024F0270
- Awardee
-
Biocryst Pharmaceuticals Inc. UEI MGXADJ6SCLJ5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $357,245
Award facts
- Contract value 100% obligated
- $357,245.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$30,373 | |
| Funding Only Action | $2,170 | |
| Original award | $385,448 |
About this award
Biocryst Pharmaceuticals Inc. has been awarded a delivery order valued at $357,245.48 for a bulk purchase of ORLADEYO (berotralstat), a specialized pharmaceutical treatment for hereditary angioedema. This award, issued on March 12, 2024, with an ultimate completion date of March 11, 2025, represents a 2025 price increase for 3 of 13 quantity line items. The contract utilizes firm fixed pricing under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries no set-aside designation, indicating open market competition. The Veterans Integrated Service Network 20, a civilian component of the Department of Veterans Affairs, is the funding agency, with performance to occur in Earth City, Missouri.
This delivery order falls under Biocryst's broader federal contracting relationship with the VA, where the company maintains significant Indefinite Delivery Vehicles including a $10 million Blanket Purchase Agreement awarded in May 2021. Biocryst specializes in developing and supplying rare disease pharmaceuticals, with ORLADEYO and RAPIVAB representing its primary federal products. The company's consistent procurement relationship with multiple VA regional networks demonstrates its critical role in supporting specialized veteran healthcare services. As a for-profit biotechnology firm headquartered in Durham, North Carolina, and registered in SAM.gov since 2006, Biocryst has established itself as a reliable federal supplier of high-value pharmaceutical products for complex medical conditions.
Quick answers
Who was awarded contract 36C26024F0270?
36C26024F0270 was awarded to Biocryst Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 12, 2024.
How much is contract 36C26024F0270 worth?
The government has obligated $357,245 on 36C26024F0270.
Is contract 36C26024F0270 an order under another contract?
Yes. 36C26024F0270 is a delivery order under 36F79721D0166, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0270 competed?
The extent of competition for 36C26024F0270 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award